Sunshine Biopharma (SBFM) Profit After Tax (2010 - 2026)
Sunshine Biopharma (SBFM) posted Profit After Tax of -$1.5 million for Q1 2026, up 42.57% on a QoQ basis from -$2.7 million in Q4 2025, and down 31.93% year-over-year from -$2.2 million in Q1 2025.
Sunshine Biopharma (SBFM) Profit After Tax (2010 - 2026) Analysis & Trends
Sunshine Biopharma's Profit After Tax history runs 16 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- Quarterly Profit After Tax fell 31.93% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.4 million (down 66.54% YoY) and the FY2025 annual result came in at -$6.0 million, down 16.39% from the prior year.
- Profit After Tax was -$1.5 million for Q1 2026 at Sunshine Biopharma, up from -$2.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$346163.0 in Q3 2024 and bottomed at -$23.3 million in Q4 2022.
- A 5-year average of -$2.6 million and a median of -$1.5 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 2915.57% — and 2023, when it jumped 96.75%.
- Sunshine Biopharma's Profit After Tax stood at -$23.3 million in 2022, then soared by 96.75% to -$758468.0 in 2023, then slumped by 115.0% to -$1.6 million in 2024, then sank by 62.51% to -$2.7 million in 2025, then surged by 42.57% to -$1.5 million in 2026.
- Business Quant data shows SBFM's Profit After Tax at -$1.5 million in Q1 2026, -$2.7 million in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | -1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.52 Mn |
| Dec 31, 2025 | -2.65 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | -1.77 Mn |
| Mar 31, 2025 | -1.15 Mn |
| Dec 31, 2024 | -1.63 Mn |
| Sep 30, 2024 | -346,163.00 |
| Jun 30, 2024 | -1.33 Mn |
| Mar 31, 2024 | -1.83 Mn |
| Dec 31, 2023 | -758,468.00 |
| Sep 30, 2023 | -1.11 Mn |
| Jun 30, 2023 | -410,059.00 |
| Mar 31, 2023 | -1.69 Mn |
| Dec 31, 2022 | -23.33 Mn |
| Sep 30, 2022 | -1.50 Mn |
| Jun 30, 2022 | -551,517.00 |
| Mar 31, 2022 | -1.24 Mn |
| Dec 31, 2021 | 828,512.00 |
| Sep 30, 2021 | -4.04 Mn |
| Jun 30, 2021 | -2.88 Mn |